AstraZeneca (AZ) has become the latest major drugmaker to announce a significant investment in the US, committing $50bn into ...

AstraZeneca has announced $50bn investment plans in the US by 2030 for drug manufacturing and research and development (R&D).

AstraZeneca to invest $50 billion in America for medicines manufacturing and R&D: Cambridge, UK Wednesday, July 23, 2025, 09:00 Hrs [IST] AstraZeneca announces $50 billion of inve ...

AstraZeneca has increased its investment in U.S. operations more than 14-fold, committing $50 billion to a range of ...

Cambridge UK headquartered pharma giant AstraZeneca is investing $50 billion across the US in the next five years, dodging ...

AstraZeneca plans to construct a multi-billion dollar manufacturing center focused on chronic diseases in Virginia within the next five years.

Photo: Alamy President Donald Trump announced a multi-billion-dollar investment from a major medical company on Tuesday, ...

AstraZeneca said it would invest $50 billion in U.S. production by 2030. At the core is a manufacturing plant to go somewhere in Virginia.

AstraZeneca plans a $50 billion investment in U.S. facilities by 2030, including a Virginia plant focused on weight loss and ...

As President Donald Trump’s tariff policies loom, global pharmaceutical giant AstraZeneca will invest $50 billion to boost ...

AstraZeneca unveils a $50 billion U.S. manufacturing expansion plan, anchored by a Virginia facility to boost drug output and ...